You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aromatase inhibitor

Showing 1 - 25 of 7,800
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • New York, New York
    Pfizer New York
Oct 11, 2023

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain Trial in Los Angeles, Torrance (Tart

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Tart Cherry
  • Omega 3 FA (Fish Oil)
  • Los Angeles, California
  • +1 more
Nov 7, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS), Breast Cancer Trial in Tucson (Initial blood draw, Initial SWE

Completed
  • Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)
  • Breast Cancer
  • Initial blood draw
  • +4 more
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 16, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Vasomotor Symptoms Trial (oxybutynin ER, Paroxetine CR)

Not yet recruiting
  • Vasomotor Symptoms
  • oxybutynin ER
  • Paroxetine CR
  • (no location specified)
Dec 1, 2022

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +4 more
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 24, 2023

Musculoskeletal Syndrome Trial in Minneapolis (CBD-dominant, THC dominant)

Recruiting
  • Musculoskeletal Syndrome
  • Minneapolis, Minnesota
    University of Minnesota
Jun 28, 2023

Palbociclib in Combination With an Aromatase Inhibitor

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib + an aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    10017
May 2, 2022

Breast Cancer, ER Positive Breast Cancer Trial in Lebanon (Letrozole 2.5mg)

Recruiting
  • Breast Cancer
  • ER Positive Breast Cancer
  • Letrozole 2.5mg
  • Lebanon, New Hampshire
  • +1 more
Dec 19, 2022

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Arthralgia, Breast Cancer Trial in Ann Arbor (Cannabidiol (CBD))

Recruiting
  • Arthralgia
  • Breast Cancer
  • Cannabidiol (CBD)
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Sep 21, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +2 more
  • Questionnaire Administration
  • Tonation Breathing Technique
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Musculoskeletal Pain Trial in Frederiksberg (Physiotherapeutic treatment and medical care, medical care)

Recruiting
  • Musculoskeletal Pain
  • Physiotherapeutic treatment and medical care
  • medical care
  • Frederiksberg, Denmark
    Parker Instituttet, Frederiksberg Hospital
Oct 7, 2022

Pre-menopausal Metastatic Breast Cancer Patients Treated With

Completed
  • Metastatic Breast Cancer
  • Palbociclib + aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    Pfizer New York
Feb 25, 2022

Breast Cancer Trial (Abemaciclib, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Nov 14, 2023

Breast Cancer Trial in Taichung (Diclofenac)

Completed
  • Breast Cancer
  • Taichung, Taiwan
    China Medical University Hospital
Jul 18, 2022

Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
  • +2 more
Jan 12, 2023

Examining the Effect of Endocrine Therapy on Aging

Recruiting
  • Breast Neoplasm Female
  • +2 more
  • Aromatase inhibitor
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 17, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Breast Cancer, Hormone Receptor Positive Tumor Trial in Tampa (Durvalumab, Anastrozole 1mg, Letrozole 2.5mg)

Terminated
Has Results
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
May 27, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Arthralgia Trial (acupuncture, Guizhi-Shaoyao-Zhimu decoction)

Not yet recruiting
  • Arthralgia
  • acupuncture
  • Guizhi-Shaoyao-Zhimu decoction
  • (no location specified)
Mar 2, 2022